资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer.

Onco Targets Ther. 2018;

GaoSong，ZhaoZhiying，WuRong，WuLina，TianXin，ZhangZhen

Products/Services Used	Details	Operation
Recombinant Proteins	… Transfection. Cells were cultured for 24 h and seeded into 96-well plate for transfection. miR-194 mimic (20 nmol/L) and negative control (NC) (20 nmol/L) were purchased from Genscript (Shanghai, China) and were used according to manufacturer's protocol …	Get A Quote

摘要

Prostate cancer (PCa) is one of the most common malignancies in men. However， a lack of understanding of the mechanism underlying PCa metastasis has strongly limited the effectiveness of therapy for this disease. Thus， investigating the mechanism of PCa may help improve the prognosis of PCa patients. The goal of this study was to investigate the role of microRNA-194 (miR-194) in PCa.